These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7986469)

  • 1. Unchanged neurogenic vasoconstrictor response after exercise during angiotensin converting enzyme inhibition with fosinopril.
    Beaulieu M; Lacourcière Y; Cléroux J
    Am J Hypertens; 1994 Aug; 7(8):763-6. PubMed ID: 7986469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiotensin converting enzyme inhibitors fosinopril and enalapril differ in their central nervous effects in humans.
    Derad I; Otterbein A; Mölle M; Pietrowsky R; Born J; Fehm HL
    J Hypertens; 1996 Nov; 14(11):1309-15. PubMed ID: 8934359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-exercise reduction in blood pressure in hypertensive subjects: effects of angiotensin converting enzyme inhibition.
    Beaulieu M; Nadeau A; Lacourcière Y; Cléroux J
    Br J Clin Pharmacol; 1993 Oct; 36(4):331-8. PubMed ID: 12959311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans.
    Massien C; Azizi M; Guyene TT; Vesterqvist O; Mangold B; Ménard J
    Clin Pharmacol Ther; 1999 Apr; 65(4):448-59. PubMed ID: 10223783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.
    Cesari M; Kritchevsky SB; Atkinson HH; Penninx BW; Di Bari M; Tracy RP; Pahor M
    Am Heart J; 2009 Feb; 157(2):334.e1-8. PubMed ID: 19185642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fosinopril on renal function, baroreflex response and noradrenaline pressor response in conscious normotensive dogs.
    Buranakarl C; Kijtawornrat A; Nampimoon P
    Vet Res Commun; 2001 Jul; 25(5):355-66. PubMed ID: 11469507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of peripheral microvascular dysfunction during long-term treatment with the angiotensin-converting enzyme inhibitor fosinopril in congestive heart failure.
    Galatius S; Wroblewski H; Sørensen V; Haunsø S; Nørgaard T; Kastrup J
    J Card Fail; 1999 Mar; 5(1):17-24. PubMed ID: 10194656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of quinapril, atenolol, and verapamil on blood pressure and forearm hemodynamics during handgrip exercise.
    Cléroux J; Beaulieu M; Kouamé N; Lacourcière Y
    Am J Hypertens; 1994 Jun; 7(6):566-70. PubMed ID: 7917158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD.
    Shrikrishna D; Tanner RJ; Lee JY; Natanek A; Lewis A; Murphy PB; Hart N; Moxham J; Montgomery HE; Kemp PR; Polkey MI; Hopkinson NS
    Chest; 2014 Oct; 146(4):932-940. PubMed ID: 24556825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential responses to sympathetic stimulation in the cerebral and brachial circulations during rhythmic handgrip exercise in humans.
    Hartwich D; Fowler KL; Wynn LJ; Fisher JP
    Exp Physiol; 2010 Nov; 95(11):1089-97. PubMed ID: 20851860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.
    Cesari M; Pedone C; Incalzi RA; Pahor M
    J Am Med Dir Assoc; 2010 Jan; 11(1):26-32. PubMed ID: 20129212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fosinopril on cardiac function in patients with hypertension. Radionuclide assessment of left ventricular systolic and diastolic performance.
    Zusman RM; Christensen DM; Higgins J; Boucher CA
    Am J Hypertens; 1992 Apr; 5(4 Pt 1):219-23. PubMed ID: 1534664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise hyperemia and vasoconstrictor responses in humans with cystic fibrosis.
    Schrage WG; Wilkins BW; Dean VL; Scott JP; Henry NK; Wylam ME; Joyner MJ
    J Appl Physiol (1985); 2005 Nov; 99(5):1866-71. PubMed ID: 16037400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post acute myocardial infarction: the Fosinopril in Acute Myocardial Infarction Study (FAMIS).
    Borghi C; Marino P; Zardini P; Magnani B; Collatina S; Ambrosioni E
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):247S-254S. PubMed ID: 9366281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fosinopril on cardiac and metabolic parameters in patients with NIDDM.
    Holdaway IM; Gamble GD; Sanders GA; Greaves SC; Ellis-Pegler EM; Sharpe N
    Diabetes Care; 1994 Dec; 17(12):1476-9. PubMed ID: 7882821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril.
    Galatius-Jensen S; Wroblewski H; Emmeluth C; Bie P; Haunsø S; Kastrup J
    Cardiovasc Res; 1996 Dec; 32(6):1148-54. PubMed ID: 9015418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group.
    Erhardt L; MacLean A; Ilgenfritz J; Gelperin K; Blumenthal M
    Eur Heart J; 1995 Dec; 16(12):1892-9. PubMed ID: 8682023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of heart failure with fosinopril: an angiotensin converting enzyme inhibitor with a dual and compensatory route of excretion.
    Mancia G; Giannattasio C; Grassi G
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):236S-241S. PubMed ID: 9366279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study.
    Maschio G; Cagnoli L; Claroni F; Fusaroli M; Rugiu C; Sanna G; Sasdelli M; Zuccalà A; Zucchelli P
    Nephrol Dial Transplant; 1994; 9(3):265-9. PubMed ID: 8052432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.